Neothetics Inc (NEOT.OQ)

NEOT.OQ on NASDAQ Stock Exchange Capital Market

15 Dec 2017
Change (% chg)

$0.01 (+0.61%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Latest Key Developments (Source: Significant Developments)

Neothetics to pay $1.5 mln‍​‍​ to Evofem Biosciences if deal terminated
Tuesday, 17 Oct 2017 

Oct 17 (Reuters) - Neothetics Inc :Neothetics says if merger agreement with Evofem Biosciences terminated under specified circumstances, co to pay Evofem termination fee of up to $1.5 mln‍​‍​.  Full Article

Neothetics Inc and Evofem Biosciences Inc announce merger agreement to create Women’S health company
Tuesday, 17 Oct 2017 

Oct 17 (Reuters) - Neothetics Inc :Neothetics Inc and Evofem Biosciences, Inc. announce merger agreement to create Women’S health company.Neothetics Inc - ‍privately-held Evofem Biosciences will merge with a wholly-owned subsidiary of Neothetics in an all-stock transaction​.Neothetics - ‍Invesco Asset Management entered securities purchase agreement to acquire additional $20 million of common stock in combined Co​.Neothetics Inc - ‍transactions have been approved by board of directors of both companies​.Neothetics - Neothetics will be renamed Evofem Biosciences and will be under leadership of Evofem Biosciences' CEO Saundra Pelletier​.Neothetics Inc - merger ‍exchange ratio assumes $171.4 million in value of Co's common stock will be issued to Evofem Biosciences stockholders in merger​.Neothetics - current Neothetics stockholders to own about 13% of combined company & current Evofem stockholders to own about 87% of combined company​.Neothetics Inc - ‍merger exchange ratio assumes $28.6 million in value of common stock being retained by Neothetics stockholders​.Neothetics Inc - ‍following merger, company will be led by Saundra Pelletier as chief executive officer​.  Full Article

Neothetics reports Q1 loss per share $0.44
Thursday, 12 May 2016 

Neothetics Inc : Neothetics reports first quarter 2016 financial results .Q1 loss per share $0.44.  Full Article

Neothetics, Inc announces leadership change
Friday, 19 Feb 2016 

Neothetics, Inc:Announces leadership change and preliminary update on lipo-202.Says George Mahaffey offered resignation as Chief Executive Officer and Chairman of the board.Says board has formed a committee to oversee day to day operations until a replacement is found.Evaluating path forward with modified formulation of lead asset lipo-202 for reduction of central abdominal bulging due to subcutaneous fat.  Full Article

BRIEF-Neothetics qtrly loss per share ‍$0.13​

* Neothetics provides business update and reports third quarter 2017 financial results